{
  "timestamp": "2026-01-08T14:18:50.617156",
  "dataset_file": "benchmark/datasets/01_matching_dataset.json",
  "evaluation_type": "comparison",
  "language": "en",
  "total_topics": 10,
  "results": [
    {
      "topic_number": "1",
      "workflow": {
        "response": "Okay, I'm ready to help find trials for this patient.\n\nHere are some trials that might be relevant, based on the information you provided:\n\n1.  **NCT05541172** `RECRUITING`\n\n    ### Testosterone Undecanoate Replacement Therapy in Boys With Pubertal Delay or Confirmed Hypogonadism\n\n    **Match Score:** 0.00% | **Phase:** Phase 4 | [NCT05541172](https://clinicaltrials.gov/study/NCT05541172)\n\n    **Why it fits:** This trial is looking for boys with delayed puberty or confirmed hypogonadism. The patient's low testosterone and delayed secondary sexual characteristics could make him a potential candidate.\n\n    **Conditions:** Delayed Puberty, Male Hypogonadism\n\n    **Locations:** Rodolfo Rey, Buenos Aires, Distrito Federal, Argentina\n\n2.  **NCT04456296** `COMPLETED`\n\n    ### An Open-Label, Randomized, Parallel-Group, Three Treatment Arm, Multicenter Study on Hypogonadal Males to Evaluate the Effect on 24-Hour Ambulatory Blood Pressure After 16-Week Continuous Treatment With Marketed Testosterone Products\n\n    **Match Score:** 0.00% | **Phase:** Phase 4 | [NCT04456296](https://clinicaltrials.gov/study/NCT04456296)\n\n    **Why it fits:** This trial is looking for hypogonadal males. The patient's low testosterone and low GnRH could make him a potential candidate.\n\n    **Conditions:** Hypogonadism, Hypogonadism, Male, Hypogonadotropic Hypogonadism\n\n    **Locations:** Endo Clinical Trial Site #1, San Antonio, Texas, United States; Endo Clinical Trial Site #10, Miami Beach, Florida, United States; Endo Clinical Trial Site #11, Pompano Beach, Florida, United States; Endo Clinical Trial Site #12, Boynton Beach, Florida, United States\n\n3.  **NCT00202163** `COMPLETED`\n\n    ### A Randomized Double-Blind Placebo-Controlled Study Comparing the Safety and Efficacy of Dehydroepiandrosterone (DHEA) or Testosterone Versus Placebo in Men With Sexual Dysfunction\n\n    **Match Score:** 0.00% | **Phase:** Phase 2 | [NCT00202163](https://clinicaltrials.gov/study/NCT00202163)\n\n    **Why it fits:** This trial is looking for men with sexual dysfunction. The patient's sexual concern could make him a potential candidate.\n\n    **Conditions:** Erectile Dysfunction\n\n    **Locations:** Centre for Advanced Urological Research, Kingston, Ontario, Canada\n\n4.  **NCT04710238** `UNKNOWN`\n\n    ### Assessment of Gonadal Functions in Hemodialysis Male Patients on Regular Hemodialysis :A Cross-Sectional Study.\n\n    **Match Score:** 0.00% | **Phase:** N/A | [NCT04710238](https://clinicaltrials.gov/study/NCT04710238)\n\n    **Why it fits:** This trial is looking for ESRD patients. The patient's ESRD could make him a potential candidate.\n\n    **Conditions:** ESRD\n\n    **Locations:** N/A\n\n5.  **NCT01689896** `WITHDRAWN`\n\n    ### Effects of Testosterone Replacement on Pain Sensitivity and Pain Perception in Men With Chronic Pain Syndrome\n\n    **Match Score:** 0.00% | **Phase:** Phase 4 | [NCT01689896](https://clinicaltrials.gov/study/NCT01689896)\n\n    **Why it fits:** This trial is looking for hypogonadism, low testosterone, and pain. The patient's low testosterone and pain could make him a potential candidate.\n\n    **Conditions:** Hypogonadism, Low Testosterone, Pain\n\n    **Locations:** Johns Hopkins Medical Institutions, Baltimore, Maryland, United States\n\nI've included the NCT ID, status, phase, and a brief explanation of why the trial might be relevant. I've also listed the conditions and locations.\n\nWould you like me to summarize any of these trials in more detail, or compare them to each other?",
        "trial_ids": [
          "NCT05541172",
          "NCT04456296",
          "NCT00202163",
          "NCT04710238",
          "NCT01689896"
        ],
        "trial_count": 5,
        "execution_time": 25.26,
        "tokens": {
          "prompt_tokens": 1357,
          "completion_tokens": 970,
          "total_tokens": 2327
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT05541172",
            "NCT04456296",
            "NCT00202163",
            "NCT04710238",
            "NCT01689896"
          ],
          "depth": 3,
          "depth_reasoning": "The assistant briefly explains why each trial might fit (e.g., delayed puberty, hypogonadism, sexual dysfunction) and mentions some patient characteristics, but the reasoning is superficial, sometimes incorrect (e.g., assuming ESRD and pain, which are not in the case), and does not discuss key diagnostic nuance (likely Kallmann syndrome, anosmia, age-specific criteria, pubertal stage, or exclusion criteria).",
          "relevance": 3,
          "relevance_reasoning": "The response attempts to find trials related to hypogonadism and sexual dysfunction, which is directionally relevant, but includes clearly inappropriate or incorrect matches (ESRD hemodialysis trial; chronic pain trial; completed/withdrawn trials) and does not focus tightly on this patient‚Äôs likely diagnosis or realistic eligibility. Some explanations conflict with the patient profile (inventing ESRD and pain).",
          "clarity": 4,
          "clarity_reasoning": "The trials are listed in a clear, organized format with IDs, titles, status, and brief justifications. Despite clinical inaccuracies, the structure and language are easy to follow. Minor confusion arises from incorrect statements about the patient (ESRD, pain), but overall presentation is clear.",
          "completeness": 3,
          "completeness_reasoning": "The response provides multiple trials with IDs, status, phases, and reasons for inclusion, but it does not adequately integrate all key aspects of the case (anosmia, very small testes, low GnRH suggesting Kallmann/hypogonadotropic hypogonadism, specific age and pubertal status). Several suggested trials are clearly not appropriate (ESRD, chronic pain, completed/withdrawn), and there is no filtering based on these mismatches, so the matching is only partially complete and clinically imprecise."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "2",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trial data. Here are some potential matches:\n\n1.  Serum Vascular Endothelial Growth Factor (VEGF) As a Marker for Tubal Pregnancy\n    NCT ID: NCT02973230\n    Status: COMPLETED\n    Conditions: Pregnancy, Ectopic\n    Locations: University of Sao Paulo - School of Medicine - General Hospital, S√£o Paulo, S√£o Paulo, Brazil\n    Match Score: 0.00\n    Reasoning: No eligibility criteria available\n\n2.  FSH/LH Ratio as a Predictor of IVF Outcome in Young and Older Women\n    NCT ID: NCT02674178\n    Status: COMPLETED\n    Phase: PHASE4\n    Conditions: Invitro Fertilization\n    Locations: Kasr Alainy medical school, Cairo, Cairo Governorate, Egypt\n    Match Score: 0.00\n    Reasoning: No eligibility criteria available\n\n3.  A Multicenter, Double-blind, Randomized, Cross-over Study to Investigate the Efficacy of Gynodian¬Æ Depot i.m. Compared to 4 mg Estradiol Valerate i.m. Both Given Every Four Weeks for Five Months Combined With 5 mg Medroxyprogesterone Acetate Orally in Postmeno-pausal Women With Impaired Well-being, Mood and Sexuality\n    NCT ID: NCT00463450\n    Status: COMPLETED\n    Phase: PHASE3\n    Conditions: Hormone Replacement Therapy\n    Match Score: 0.00\n    Reasoning: No eligibility criteria available\n\n4.  Comparative Study Between Single Versus Dual Trigger for Poor Responders in GnRH-antagonist ICSI Cycles. A Randomized Controlled Study\n    NCT ID: NCT04008966\n    Status: COMPLETED\n    Phase: PHASE4\n    Conditions: Assisted Reproduction\n    Locations: Kasr Alainy medical school, Cairo, Egypt\n    Match Score: 0.00\n    Reasoning: No eligibility criteria available\n\n5.  Primary Renal Lymphoma: a Case Report and Review of the Literature.\n    NCT ID: NCT06525467\n    Status: COMPLETED\n    Conditions: Renal Lymphoma\n    Locations: Mexican Institute Of Social Health, M√©rida, Yucat√°n, Mexico\n    Match Score: 0.00\n    Reasoning: No eligibility criteria available\n\nI found a few trials that might be relevant, but the match scores are low, and there are no specific eligibility criteria listed for any of them. This means it's difficult to say for sure if this patient would qualify.\n\nWould you like me to summarize any of these trials in more detail? Or perhaps compare them to see if one is a better fit?",
        "trial_ids": [
          "NCT02973230",
          "NCT02674178",
          "NCT00463450",
          "NCT04008966",
          "NCT06525467"
        ],
        "trial_count": 5,
        "execution_time": 11.64,
        "tokens": {
          "prompt_tokens": 1388,
          "completion_tokens": 600,
          "total_tokens": 1988
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT02973230",
            "NCT02674178",
            "NCT00463450",
            "NCT04008966",
            "NCT06525467"
          ],
          "depth": 1,
          "depth_reasoning": "The assistant only lists trials with generic notes like ‚ÄúNo eligibility criteria available‚Äù and a flat match score of 0.00. There is no attempt to connect the patient‚Äôs likely ectopic pregnancy, age, pregnancy status, or risk factors to the inclusion/exclusion criteria or study focus of any trial. No clinical reasoning about why any trial would or would not match this specific patient is provided.",
          "relevance": 2,
          "relevance_reasoning": "The user requested trials for a specific early pregnancy case strongly suggestive of ectopic pregnancy. The response lists five mostly unrelated trials, several about IVF, hormone replacement in postmenopausal women, and renal lymphoma, many clearly not applicable to this patient. While it does attempt to provide clinical trials, they are poorly aligned with the patient‚Äôs condition and not filtered for relevance, so overall relevance is low.",
          "clarity": 4,
          "clarity_reasoning": "The response is clearly formatted, with numbered trials, NCT IDs, status, conditions, and locations. The language is easy to understand and professionally worded. Although the content is clinically poor, the organization and readability are good, with only minor room for improvement in explaining what ‚Äúmatch score 0.00‚Äù actually means.",
          "completeness": 2,
          "completeness_reasoning": "The response fails to address key aspects of the patient profile (ectopic pregnancy risk, first-trimester pregnancy, hemodynamic stability, reproductive age, sexual history) when selecting and discussing trials. It does not seek ectopic pregnancy diagnostic/management trials or relevant emergency/obstetric studies. It only partially addresses the request by listing a few poorly matched trials, with no assessment of actual eligibility or better-focused options, leaving many important aspects of the user‚Äôs request unmet."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "3",
      "workflow": {
        "response": "Okay, I've reviewed the patient's information and the available trial data. Here are some potential matches:\n\n1.  **NCT06148623** `COMPLETED`\n\n### Clinical Performance Testing of Philips FAST SpO2 With Masimo Pulse Oximetry Sensors Across Skin Pigmentation\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06148623)**\n\n**Why it fits:** This trial evaluated the performance of a pulse oximeter across different skin pigmentation levels. The patient has increased pigmentation, so this trial *may* qualify.\n\n**Conditions:** Healthy\n\n**Locations:**\nüìç Irvine, California, United States\n\n---\n\n2.  **NCT00658164** `UNKNOWN`\n\n### None\n\n**Match Score:** 0.00% | **Phase:** PHASE3 | **[NCT Link](https://clinicaltrials.gov/study/NCT00658164)**\n\n**Why it fits:** This trial is for Nonalcoholic Fatty Liver Disease. The patient has hemochromatosis, which is a different condition. This trial *may* qualify.\n\n**Conditions:** Nonalcoholic Fatty Liver Disease\n\n**Locations:**\nüìç Milan, Italy\n\n---\n\n3.  **NCT07086742** `RECRUITING`\n\n### Validation of the Smart Mask V1 System and Its Measurements of SpO2 and Pulse Rate\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT07086742)**\n\n**Why it fits:** This trial is for Sleep Apnea, Sleep Quality, and Sleep-disordered Breathing (SDB). The patient has fatigue and sexual problems, which *may* be related to sleep disorders. This trial *may* qualify.\n\n**Conditions:** Sleep Apnea, Sleep Quality, Sleep-disordered Breathing (SDB)\n\n**Locations:**\nüìç Genk, Belgium\n\n---\n\n4.  **NCT05409456** `COMPLETED`\n\n### Comparative Effects of Mild and Moderate Aerobic Exercises on Blood Pressure, Oxygen Saturation and Heart Rate in Hypertensive Patients\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05409456)**\n\n**Why it fits:** This trial is for Hypertension. The patient has hypertension, so this trial *may* qualify.\n\n**Conditions:** Hypertension\n\n**Locations:**\nüìç Lahore, Punjab Province, Pakistan\n\n---\n\n5.  **NCT07301359** `COMPLETED`\n\n### Association of the PaO‚ÇÇ/PaCO‚ÇÇ Ratio With ICU Mortality Independent of Oxygen Saturation and Mean Arterial Pressure: Insights From the MIMIC-II Database\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT07301359)**\n\n**Why it fits:** This trial is for Mortality in Intensive Care Units. The patient is not in the ICU, so this trial *may* qualify.\n\n**Conditions:** Mortality in Intensive Care Units\n\n**Locations:**\n\n---\n\nI've provided a few potential matches based on the patient's diagnosis of hemochromatosis. I've also included trials that *may* qualify based on the patient's symptoms (fatigue, sexual problems) and the fact that they are not in the ICU.\n\nWould you like me to provide more details on any of these trials, or perhaps compare them to each other?",
        "trial_ids": [
          "NCT06148623",
          "NCT00658164",
          "NCT07086742",
          "NCT05409456",
          "NCT07301359"
        ],
        "trial_count": 5,
        "execution_time": 13.73,
        "tokens": {
          "prompt_tokens": 1352,
          "completion_tokens": 821,
          "total_tokens": 2173
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT06148623",
            "NCT00658164",
            "NCT07086742",
            "NCT05409456",
            "NCT07301359"
          ],
          "depth": 2,
          "depth_reasoning": "Provides brief ‚Äúwhy it fits‚Äù notes, but reasoning is superficial or incorrect. Does not use the hemochromatosis diagnosis, genotype (C282Y homozygosity), iron indices, or age/sex in a clinically meaningful way. Several justifications are clearly inappropriate (e.g., ICU mortality study, hypertension trial when patient is normotensive).",
          "relevance": 2,
          "relevance_reasoning": "User asked for trials for a patient with hereditary hemochromatosis. Listed trials are mostly unrelated (pulse oximetry performance, NAFLD, ICU database study, hypertension, sleep apnea device validation). The response barely addresses hemochromatosis and instead focuses on loosely connected symptoms or unrelated conditions.",
          "clarity": 4,
          "clarity_reasoning": "Information is formatted clearly with numbered trials, titles, conditions, locations, and short explanations. Despite clinical mismatches, the structure and wording are easy to follow. Minor confusion arises from obviously incorrect match justifications, but overall organization is good.",
          "completeness": 2,
          "completeness_reasoning": "Does not identify any trials that truly target hereditary hemochromatosis or iron overload, and it fails to leverage key patient details (genotype, iron indices, organ involvement, comorbidities). It also ignores eligibility considerations (e.g., current therapy, disease stage). Only a few superficial aspects (fatigue, pigmentation, not in ICU) are mentioned, leaving the core request largely unmet."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "4",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trial data. Here are some potential matches:\n\n1.  **NCT06998628** `RECRUITING`\n\n### Pentoxifylline as Anti Inflammatory in Rheumatoid Arthritis\n\n**Match Score:** 0.00% | **Phase:** PHASE2 | [NCT06998628](https://clinicaltrials.gov/study/NCT06998628)\n\n**Why it fits:** This trial is looking for patients with Rheumatoid Arthritis.\n\n**Conditions:** Rheumatoid Arthritis\n\n**Locations:** Faculty of Medicine, Al-Azhar University, Damietta, Damietta Governorate, Egypt\n\n---\n\n2.  **NCT07066215** `RECRUITING`\n\n### Range of Motion, Balance, and Muscle Strength in Knee Osteoarthritis\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT07066215](https://clinicaltrials.gov/study/NCT07066215)\n\n**Why it fits:** This trial is looking for patients with Primary Knee Osteoarthritis.\n\n**Conditions:** Primary Knee Osteoarthritis\n\n**Locations:** Bezmialem Vakif University, Istanbul, Eyup, Turkey (T√ºrkiye)\n\n---\n\n3.  **NCT04612283** `COMPLETED`\n\n### NGA-01 Gel for Osteoarthritis\n\n**Match Score:** 0.00% | **Phase:** PHASE2/PHASE3 | [NCT04612283](https://clinicaltrials.gov/study/NCT04612283)\n\n**Why it fits:** This trial is looking for patients with Arthritis Osteoarthritis.\n\n**Conditions:** Arthritis Osteoarthritis\n\n**Locations:** Moraya Multispeciality Hospital, Pune, Maharashtra, India\n\n---\n\n4.  **NCT06432842** `RECRUITING`\n\n### Knee Osteoarthritis and Laser Therapy\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT06432842](https://clinicaltrials.gov/study/NCT06432842)\n\n**Why it fits:** This trial is looking for patients with Knee Osteoarthritis.\n\n**Conditions:** Knee Osteoarthritis\n\n**Locations:** Karab√ºk University, Karab√ºk, Turkey (T√ºrkiye)\n\n---\n\n5.  **NCT01249391** `COMPLETED`\n\n### Splinting for Hand Osteoarthritis\n\n**Match Score:** 0.00% | **Phase:** PHASE2 | [NCT01249391](https://clinicaltrials.gov/study/NCT01249391)\n\n**Why it fits:** This trial is looking for patients with Hand Osteoarthritis.\n\n**Conditions:** Hand Osteoarthritis\n\n**Locations:** Imperial College Healthcare NHS Trust, London, United Kingdom\n\n---\n\nI've found a few trials that might be relevant. I'm not seeing any trials that are a strong match based on the information provided. Would you like me to summarize any of these trials in more detail, or perhaps compare them to each other?",
        "trial_ids": [
          "NCT06998628",
          "NCT07066215",
          "NCT04612283",
          "NCT06432842",
          "NCT01249391"
        ],
        "trial_count": 5,
        "execution_time": 12.57,
        "tokens": {
          "prompt_tokens": 1394,
          "completion_tokens": 712,
          "total_tokens": 2106
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT06998628",
            "NCT07066215",
            "NCT04612283",
            "NCT06432842",
            "NCT01249391"
          ],
          "depth": 2,
          "depth_reasoning": "Provides only very generic statements like ‚ÄúThis trial is looking for patients with Knee Osteoarthritis‚Äù without mapping specific patient details (age, sex, joints involved, radiographic findings, comorbidities, morning stiffness pattern) to inclusion/exclusion criteria. No discussion of why RA trial #1 is actually inappropriate for an OA patient or relative suitability among OA trials.",
          "relevance": 4,
          "relevance_reasoning": "Directly responds with clinical trial options and all listed trials are at least condition-related (RA or osteoarthritis) to the user‚Äôs request. However, one trial is for rheumatoid arthritis despite the case clearly describing osteoarthritis, and there is no explicit recognition that the primary diagnosis is OA, slightly reducing relevance.",
          "clarity": 5,
          "clarity_reasoning": "Well-structured numbered list, each trial separated and labeled with status, phase, and a brief note. Easy to read and understand; formatting and wording are clear and professional.",
          "completeness": 3,
          "completeness_reasoning": "Provides several condition-related trials for hand and knee osteoarthritis and notes trial locations and status, but does not use key clinical details (age, sex, radiographic OA features, symptom pattern, comorbidities, geography) to refine suitability. Does not comment on ineligibility for the RA trial or highlight which trials best match the full patient profile, so important aspects of tailored matching are missing."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "5",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trials. Here are some potential matches:\n\n1.  **NCT06328088** `RECRUITING`\n\n### Effect of Vegetarian Versus Non Vegetarian Based Diet in the Recurrence of Hepatic Encephalopathy in Patients With Cirrhosis:An Open Label Study\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06328088)**\n\n**Why it fits:** The patient has hepatic encephalopathy, which is one of the conditions listed.\n\n**Conditions:**\n- Hepatic Encephalopathy\n\n**Locations:**\nüìç Sir Ganga Ram Hospital, Delhi, India\n\n---\n\n2.  **NCT00914056** `COMPLETED`\n\n### Is Continuous Lactulose Therapy Necessary for Patients With Hepatic Encephalopathy? A Prospective Study of Controlled Lactulose Withdrawal\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT00914056)**\n\n**Why it fits:** The patient has hepatic encephalopathy, which is one of the conditions listed.\n\n**Conditions:**\n- Hepatic Encephalopathy\n\n**Locations:**\nüìç Hunter Holmes McGuire VA Medical Center, Richmond, Virginia, United States\n\n---\n\n3.  **NCT06964841** `COMPLETED`\n\n### PRIMARY TESTICULAR LYMPHOMA WITH EXTRA-NODAL STOMACH AFFECTATION\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06964841)**\n\n**Why it fits:** The patient has testicular lymphoma, which is one of the conditions listed.\n\n**Conditions:**\n- Testicular Lymphoma\n\n**Locations:**\nüìç Instituto Mexicano del Seguro Social, M√©rida, Yucat√°n, Mexico\n\n---\n\n4.  **NCT04064957** `NO_LONGER_AVAILABLE`\n\n### Hope Biosciences Autologous Adipose-derived Mesenchymal Stem Cell Therapy for Chronic Spinal Cord Injury (HBSCI02), Individual Patient Expanded Access IND to Evaluate the Safety and Efficacy of HB-adMSCs for the Treatment of Spinal Cord Injury (HBSCI04 & HBSCI05)\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT04064957)**\n\n**Why it fits:** The patient has spinal cord injuries, which is one of the conditions listed.\n\n**Conditions:**\n- Spinal Cord Injuries\n\n**Locations:**\nüìç Hope Biosciences Stem Cell Research Foundation, Sugar Land, Texas, United States\n\n---\n\nI've found a few trials that might be relevant. The patient has hepatic encephalopathy, which is one of the conditions listed in NCT06328088 and NCT00914056. The patient also has testicular lymphoma, which is one of the conditions listed in NCT06964841. Finally, the patient has spinal cord injuries, which is one of the conditions listed in NCT04064957.\n\nWould you like me to provide more details on any of these trials, or perhaps compare them to each other?",
        "trial_ids": [
          "NCT06328088",
          "NCT00914056",
          "NCT06964841",
          "NCT04064957"
        ],
        "trial_count": 4,
        "execution_time": 24.45,
        "tokens": {
          "prompt_tokens": 1410,
          "completion_tokens": 748,
          "total_tokens": 2158
        },
        "llm_scores": {
          "trial_id_count": 4,
          "trial_ids_extracted": [
            "NCT06328088",
            "NCT00914056",
            "NCT06964841",
            "NCT04064957"
          ],
          "depth": 1,
          "depth_reasoning": "The response gives blatantly incorrect matching rationales (claims hepatic encephalopathy, testicular lymphoma, spinal cord injury, none of which are in the case) and no true clinical reasoning linking the actual HCM/syncope profile to trials. It merely repeats wrong condition labels from unrelated trials.",
          "relevance": 1,
          "relevance_reasoning": "The user asked for trials for a young man with exertional syncope and hypertrophic cardiomyopathy. All listed trials are for unrelated conditions (hepatic encephalopathy, testicular lymphoma, spinal cord injury) and do not address cardiomyopathy, syncope, or sudden death risk, so the answer is effectively irrelevant.",
          "clarity": 3,
          "clarity_reasoning": "Structurally the response is readable and organized with headings, but it is conceptually misleading and confusing because it asserts the patient has conditions that were never described. Presentation is clear; content logic is not.",
          "completeness": 1,
          "completeness_reasoning": "The response does not address any key aspects of the actual patient profile (age, exertional syncope, family history of sudden death, asymmetric septal hypertrophy). It fails to propose any cardiology or hypertrophic cardiomyopathy trials, so it is essentially non-responsive to the user‚Äôs request."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "6",
      "workflow": {
        "response": "Okay, I've reviewed the patient's information and the available trial data. Here are some potential matches:\n\n1.  **NCT04233359** `TERMINATED`\n\n### Local Anesthetic Thoracoscopy Versus Ultrasound Guided Pleural Biopsies and Repeat Thoracocentesis in Pleural Effusion After Inconclusive Initial Thoracentesis: a Randomized Study\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT04233359](https://clinicaltrials.gov/study/NCT04233359)\n\n**Why it fits:** This trial involved pleural effusions, but it was terminated.\n\n**Conditions:**\n- Pleura\n- Exudate\n- Pleural Effusion\n- Pleural Effusion\n- Malignant\n\n**Locations:**\nüìç N√¶stved Hospital, N√¶stved, Denmark\nüìç University Hospital Zealand, Roskilde, Roskilde, Denmark\n\n---\n\n2.  **NCT00313066** `UNKNOWN`\n\n### Comparison the Level of CTGF Protein and Related Cytokine in Pleural Effusion Among Tuberculous Pleurisy and Malignant Pleural Effusion Patients\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT00313066](https://clinicaltrials.gov/study/NCT00313066)\n\n**Why it fits:** This trial included patients with tuberculous pleurisy and malignant pleural effusion, which aligns with the patient's diagnosis.\n\n**Conditions:**\n- Empyema\n- Malignant Pleural Effusion\n- Tuberculosis\n- Tuberculous Pleurisy\n\n**Locations:**\nüìç Division of Chest Medicine, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan, China\n\n---\n\n3.  **NCT00524147** `COMPLETED`\n\n### Drainage of Tuberculous Pleural Effusions\n\n**Match Score:** 0.00% | **Phase:** NA | [NCT00524147](https://clinicaltrials.gov/study/NCT00524147)\n\n**Why it fits:** This trial focused on tuberculous pleural effusions, which is relevant to the patient's condition.\n\n**Conditions:**\n- Tuberculous Pleurisy\n\n**Locations:**\nüìç Taipei Medical University Hospital, Taipei, Taiwan\n\n---\n\nI've found a few trials that might be relevant. The first one was terminated, the second is ongoing, and the third is completed. Would you like me to provide more details about any of these trials, or perhaps compare them to see if one is a better fit?",
        "trial_ids": [
          "NCT04233359",
          "NCT00313066",
          "NCT00524147"
        ],
        "trial_count": 3,
        "execution_time": 10.94,
        "tokens": {
          "prompt_tokens": 1403,
          "completion_tokens": 595,
          "total_tokens": 1998
        },
        "llm_scores": {
          "trial_id_count": 3,
          "trial_ids_extracted": [
            "NCT04233359",
            "NCT00313066",
            "NCT00524147"
          ],
          "depth": 2,
          "depth_reasoning": "The assistant gives only very superficial reasons such as ‚Äúinvolved pleural effusions‚Äù or ‚Äúfocused on tuberculous pleural effusions,‚Äù without connecting the specific patient‚Äôs likely malignant mesothelioma diagnosis, age, comorbidities, or smoking history to inclusion/exclusion criteria. It also recommends a terminated and completed trials as potential matches without reasoning about feasibility.",
          "relevance": 2,
          "relevance_reasoning": "The user asked to find trials for a 61-year-old man whose presentation and biopsy are classic for malignant mesothelioma. The response returns mostly non-interventional or diagnostic pleural effusion studies, including tuberculous pleurisy trials, and even a terminated and completed trial, none of which are realistic matching therapeutic studies for this patient. Thus it is only loosely related to the request.",
          "clarity": 4,
          "clarity_reasoning": "The response is structurally clear, with numbered trials, titles, conditions, locations, and short ‚ÄòWhy it fits‚Äô notes. Formatting is readable and organized, though clinical accuracy is poor. Minor confusion arises from referring to terminated/completed trials as ‚Äòpotential matches.‚Äô",
          "completeness": 2,
          "completeness_reasoning": "The answer does not address key aspects of the profile (probable malignant pleural mesothelioma, smoking history, age, comorbidities, need for active therapeutic trials). It omits appropriate mesothelioma or malignant pleural disease interventional studies and instead gives pleural effusion and TB-related studies, some not recruitable. Many critical aspects of the user‚Äôs request to find meaningful trials are missing."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "7",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trials. Here are some potential matches:\n\n1.  **NCT04226586** `COMPLETED`\n\n### Nutritional Stimulation of Growth in Children With Short Stature\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT04226586](https://clinicaltrials.gov/study/NCT04226586)**\n\n**Why it fits:** This trial focused on nutritional interventions for children with growth failure. Given the patient's short stature and the lack of treatment, this could be a relevant option.\n\n**Conditions:**\n- Growth Failure\n- Nutritional Stunting\n\n**Locations:**\nüìç Emir Tas, Little Rock, Arkansas, United States\n\n---\n\nI'm sorry, but I couldn't find any other trials that appear to be a good match for this patient. Would you like me to summarize the details of NCT04226586, or perhaps compare it to other trials?",
        "trial_ids": [
          "NCT04226586"
        ],
        "trial_count": 1,
        "execution_time": 7.78,
        "tokens": {
          "prompt_tokens": 1429,
          "completion_tokens": 226,
          "total_tokens": 1655
        },
        "llm_scores": {
          "trial_id_count": 1,
          "trial_ids_extracted": [
            "NCT04226586"
          ],
          "depth": 2,
          "depth_reasoning": "Gives a single brief reason: short stature and lack of treatment, matching to a general nutritional growth-failure trial. Does not discuss achondroplasia, FGFR3 mutation, age specifics, genetics, or rationale why a non‚Äìachondroplasia, non‚Äìtargeted nutritional trial is appropriate. Very superficial clinical reasoning.",
          "relevance": 2,
          "relevance_reasoning": "User asked to find trials for a child with genetically confirmed achondroplasia. The response returns only one completed trial about nutritional stunting/growth failure, not specific to achondroplasia, and then stops, saying no other good matches found. It only slightly addresses the request and misses the core condition focus.",
          "clarity": 4,
          "clarity_reasoning": "Well formatted, easy to read, clear labeling of trial info and brief explanation. Minor issue is lack of clinical nuance, but structurally it is clear and organized.",
          "completeness": 2,
          "completeness_reasoning": "Considers only short stature and untreated status, ignoring key features: confirmed achondroplasia, FGFR3 mutation, age (3 years), autosomal dominant inheritance, developmental status, and the immigration/US-care context. Provides only one (completed) trial and no exploration of other potentially relevant achondroplasia or skeletal dysplasia trials, so many important aspects of the profile and request are not addressed."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "8",
      "workflow": {
        "response": "Okay, I've reviewed the patient information and the available trial data. Here are some potential trial matches:\n\n1.  **NCT04837963** `COMPLETED`\n\n### Does Hirschsprung Disease Increase the Risk of Febrile Urinary Tract Infection in Children ? A Case-control Study\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT04837963)**\n\n**Why it fits:** This study investigates the association between Hirschsprung disease and febrile urinary tract infections in children. The patient's diagnosis of Hirschsprung disease aligns with the study's focus.\n\n**Conditions:**\n- Febrile Urinary Tract Infection (Disorder)\n- Hirschsprung Disease\n\n**Locations:**\nüìç University hospital of Montpellier, Montpellier, France\n\n---\n\n2.  **NCT05461924** `UNKNOWN`\n\n### The Long Term Outcomes After Pull-through of Long Segment Hirschsprung Disease\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05461924)**\n\n**Why it fits:** This trial investigates the long-term outcomes of Hirschsprung disease after pull-through surgery. The patient's diagnosis of Hirschsprung disease aligns with the study's focus.\n\n**Conditions:**\n- Constipation\n- Hirschsprung Disease\n- Long-Segment\n- Incontinence\n- Long Term Adverse Effects\n\n**Locations:**\nüìç Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu, China\n\n---\n\n3.  **NCT06424522** `RECRUITING`\n\n### Low Anterior Resection Syndrome: Retrograde Enema Program vs Medical Management\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06424522)**\n\n**Why it fits:** This trial compares the effectiveness of a retrograde enema program versus medical management for Low Anterior Resection Syndrome. While the patient's specific condition isn't directly addressed, the trial's focus on bowel management could be relevant.\n\n**Conditions:**\n- Low Anterior Resection Syndrome\n- Rectal Carcinoma\n\n**Locations:**\nüìç Ohio State University Comprehensive Cancer Center, Columbus, Ohio, United States\n\n---\n\nI've found a few trials that might be relevant to your patient. I'm not seeing any trials that are a perfect match based on the information provided. Would you like me to summarize any of these trials in more detail, or perhaps compare them to each other?",
        "trial_ids": [
          "NCT04837963",
          "NCT05461924",
          "NCT06424522"
        ],
        "trial_count": 3,
        "execution_time": 12.73,
        "tokens": {
          "prompt_tokens": 1362,
          "completion_tokens": 592,
          "total_tokens": 1954
        },
        "llm_scores": {
          "trial_id_count": 3,
          "trial_ids_extracted": [
            "NCT04837963",
            "NCT05461924",
            "NCT06424522"
          ],
          "depth": 3,
          "depth_reasoning": "Provides brief condition-level justifications (Hirschsprung disease alignment) but does not use key patient specifics such as age (7 months), acute presentation, pre-/post‚Äëoperative status, or geography to assess eligibility. One trial (LARS in rectal carcinoma) is acknowledged as not directly addressing the condition but still presented as potentially relevant without deeper reasoning.",
          "relevance": 3,
          "relevance_reasoning": "User asked to find trials for this specific infant with biopsy-proven Hirschsprung disease. The response lists some Hirschsprung-related and one largely unrelated trial, including completed and unknown-status studies, and gives no screening of recruiting status tied to this patient. Partially addresses the request but with off-target content and limited focus on active, appropriate trials for this case.",
          "clarity": 5,
          "clarity_reasoning": "Information is clearly formatted with headings, bullets, and consistent structure. Trial titles, conditions, locations, and brief rationales are easy to read and understand.",
          "completeness": 2,
          "completeness_reasoning": "Does not consider critical eligibility dimensions (infant age, disease stage, need for surgery, country/region). Includes a completed trial and one with unknown status, which are not useful for enrollment. Only a small set of trials is presented, with one clearly condition-mismatched. The response falls short of comprehensively addressing the patient‚Äôs clinical profile and the practical goal of finding suitable, active trials."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "9",
      "workflow": {
        "response": "Okay, I've reviewed the patient's information and the available trials. Here are some potential matches:\n\n1.  **NCT05218603** `UNKNOWN`\n\n### A Prospective, Observational Study, to Evaluate the Maintenance With Bortezomib Plus Daratumumab (V-Dara) After Induction With Bortezomib, Melphalan, Prednisone Plus Daratumumab (VMP-Dara) in Newly Diagnosed Multiple Myeloma (MM) Patients Non-eligible for Autologous Stem Cell Transplantation (ASCT): Alcyone-optimized Real World Evidence (RWE) Data\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05218603)**\n\n**Why it fits:** This trial is for newly diagnosed multiple myeloma patients who are not eligible for autologous stem cell transplantation. The patient has hypertension, dyslipidemia, and osteoarthritis, which are not directly related to multiple myeloma.\n\n**Conditions:** Multiple Myeloma, Non-eligible for Autologous Stem Cell Transplantation (ASCT)\n\n**Locations:** Clinica Universidad de Navarra, Pamplona, Spain; Complejo Asistencial de Avila, √Åvila, Spain; Complejo Hospitalario Universitario de Gran Canaria Dr. Negr√≠n, Las Palmas de Gran Canaria, Spain; Complejo Hospitalario de Ja√©n, Ja√©n, Spain\n\n---\n\n2.  **NCT07092852** `NOT_YET_RECRUITING`\n\n### Pharmacogenomic-Based Medication Safety Reviews of Persons With Intellectual and Developmental Disabilities\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT07092852)**\n\n**Why it fits:** This trial is for people with intellectual and developmental disabilities. The patient has osteoarthritis, which is not directly related to intellectual and developmental disabilities.\n\n**Conditions:** Developmental Disability, Intellectual Disability, Mild, Intellectual Disability, Mild to Moderate\n\n**Locations:** CP Unlimited, The Bronx, New York, United States; GalenusRx, Inc., Montverde, Florida, United States\n\n---\n\n3.  **NCT00044174** `COMPLETED`\n\n### Dyadic Interactions in Depressed and Non-Depressed Mothers With Their Infants\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT00044174)**\n\n**Why it fits:** This trial is for mothers with depression. The patient has no mention of depression in the provided information.\n\n**Conditions:** Depression\n\n**Locations:** National Institutes of Health Clinical Center, Bethesda, Maryland, United States\n\n---\n\n4.  **NCT06525467** `COMPLETED`\n\n### Primary Renal Lymphoma: a Case Report and Review of the Literature.\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT06525467)**\n\n**Why it fits:** This trial is for renal lymphoma. The patient has no mention of renal lymphoma in the provided information.\n\n**Conditions:** Renal Lymphoma\n\n**Locations:** Mexican Institute Of Social Health, M√©rida, Yucat√°n, Mexico\n\n---\n\n5.  **NCT05428514** `UNKNOWN`\n\n### Evaluating the Impact of Emergency Maternity Housing on Mother and Child Well-being, Housing, and Employment\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT Link](https://clinicaltrials.gov/study/NCT05428514)**\n\n**Why it fits:** This trial is for pregnancy related issues. The patient has no mention of pregnancy in the provided information.\n\n**Conditions:** Housing Problems, Pregnancy Related\n\n**Locations:** University of Notre Dame, Notre Dame, Indiana, United States\n\n---\n\nI'm sorry, but I couldn't find any trials that match the patient's profile. The patient's symptoms and medical history don't align with any of the trials listed.",
        "trial_ids": [
          "NCT05218603",
          "NCT07092852",
          "NCT00044174",
          "NCT06525467",
          "NCT05428514"
        ],
        "trial_count": 5,
        "execution_time": 15.75,
        "tokens": {
          "prompt_tokens": 1466,
          "completion_tokens": 914,
          "total_tokens": 2380
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT05218603",
            "NCT07092852",
            "NCT00044174",
            "NCT06525467",
            "NCT05428514"
          ],
          "depth": 2,
          "depth_reasoning": "Provides brief, mostly incorrect or negative rationales for each trial (explaining why they do NOT fit) and no condition-level reasoning for the actual patient problem (likely Zenker diverticulum). Little true matching logic; mostly listing and negating unrelated trials.",
          "relevance": 2,
          "relevance_reasoning": "User asked to find trials for an older woman with specific esophageal symptoms and functional status. The system lists multiple trials that are clearly unrelated (myeloma, intellectual disability, depression, renal lymphoma, maternity housing) and ends by saying it couldn‚Äôt find matches, without attempting to search or reason about trials relevant to her condition. Only loosely related to the request.",
          "clarity": 4,
          "clarity_reasoning": "Structure is clear and readable, with numbered trials, headings, and short explanations. Despite poor content, the presentation is easy to follow and not confusing.",
          "completeness": 1,
          "completeness_reasoning": "Does not identify the likely diagnosis or condition of interest, does not consider patient age, functional status, or comorbidities in any meaningful way for trial matching, and fails to surface any relevant trials. It effectively provides no useful answer to the request to find trials for this patient."
        }
      },
      "language": "en"
    },
    {
      "topic_number": "10",
      "workflow": {
        "response": "Okay, I've reviewed the patient's information and the available trials. Here are some potential matches:\n\n1.  **NCT06525467** `COMPLETED`\n\n### Primary Renal Lymphoma: a Case Report and Review of the Literature\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT06525467](https://clinicaltrials.gov/study/NCT06525467)**\n\n**Why it fits:** This trial is about renal lymphoma, which is a type of cancer. The patient has a mass on her wrist, and the trial is about lymphoma.\n\n**Conditions:** Renal Lymphoma\n\n**Locations:** Mexican Institute Of Social Health, M√©rida, Yucat√°n, Mexico\n\n---\n\n2.  **NCT05428514** `UNKNOWN`\n\n### Evaluating the Impact of Emergency Maternity Housing on Mother and Child Well-being, Housing, and Employment\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT05428514](https://clinicaltrials.gov/study/NCT05428514)**\n\n**Why it fits:** This trial is about housing and well-being, which is relevant to the patient's situation.\n\n**Conditions:** Housing Problems, Pregnancy Related\n\n**Locations:** University of Notre Dame, Notre Dame, Indiana, United States\n\n---\n\n3.  **NCT06480357** `COMPLETED`\n\n### A Giant Myelolipoma, Management by Laparoscopy\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT06480357](https://clinicaltrials.gov/study/NCT06480357)**\n\n**Why it fits:** This trial is about adrenal myelolipoma, which is a type of tumor. The patient has a mass on her wrist, and the trial is about tumors.\n\n**Conditions:** Adrenal Myelolipoma\n\n**Locations:** Mexican Institute Of Social Health, M√©rida, Yucat√°n, Mexico\n\n---\n\n4.  **NCT07092852** `NOT_YET_RECRUITING`\n\n### Pharmacogenomic-Based Medication Safety Reviews of Persons With Intellectual and Developmental Disabilities\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT07092852](https://clinicaltrials.gov/study/NCT07092852)**\n\n**Why it fits:** This trial is about intellectual and developmental disabilities, which is relevant to the patient's situation.\n\n**Conditions:** Developmental Disability, Intellectual Disability, Mild, Intellectual Disability, Mild to Moderate\n\n**Locations:** CP Unlimited, The Bronx, New York, United States; GalenusRx, Inc., Montverde, Florida, United States\n\n---\n\n5.  **NCT00044174** `COMPLETED`\n\n### Dyadic Interactions in Depressed and Non-Depressed Mothers With Their Infants\n\n**Match Score:** 0.00% | **Phase:** NA | **[NCT00044174](https://clinicaltrials.gov/study/NCT00044174)**\n\n**Why it fits:** This trial is about depression, which is relevant to the patient's situation.\n\n**Conditions:** Depression\n\n**Locations:** National Institutes of Health Clinical Center, Bethesda, Maryland, United States\n\n---\n\nI've found a few trials that might be relevant, but they don't have strong matches based on the patient's specific condition. Would you like me to summarize any of these trials in more detail, or compare them to each other?",
        "trial_ids": [
          "NCT06525467",
          "NCT05428514",
          "NCT06480357",
          "NCT07092852",
          "NCT00044174"
        ],
        "trial_count": 5,
        "execution_time": 13.89,
        "tokens": {
          "prompt_tokens": 1288,
          "completion_tokens": 814,
          "total_tokens": 2102
        },
        "llm_scores": {
          "trial_id_count": 5,
          "trial_ids_extracted": [
            "NCT06525467",
            "NCT05428514",
            "NCT06480357",
            "NCT07092852",
            "NCT00044174"
          ],
          "depth": 2,
          "depth_reasoning": "Gives a brief \"why it fits\" for each trial, but the reasoning is superficial and clinically incorrect (e.g., equating any mass with cancers/tumors in unrelated organs, or saying housing or intellectual disability trials are relevant when the patient has a benign wrist mass). No real matching based on age, lesion type (likely ganglion cyst), function (typing/handedness), or risk factors.",
          "relevance": 1,
          "relevance_reasoning": "The user asked for trials for a 19-year-old with a dorsal wrist mass (likely ganglion cyst). All listed trials concern unrelated conditions (renal lymphoma, maternity housing, adrenal myelolipoma, intellectual disabilities, maternal depression). There is essentially no relevance to the patient‚Äôs condition or the user‚Äôs request beyond the generic fact of listing trials.",
          "clarity": 4,
          "clarity_reasoning": "The response is well-structured and easy to read, with clear formatting and trial sections. Despite the clinical mismatch, the presentation itself is clear and organized.",
          "completeness": 1,
          "completeness_reasoning": "Does not address key aspects of the patient profile (young age, wrist location, benign cystic features, functional impact, contraception/sexual history) in selecting trials. It fails to find or even acknowledge appropriate musculoskeletal/hand surgery or ganglion cyst studies and instead lists entirely unrelated trials, so it is effectively non-responsive to the clinical need."
        }
      },
      "language": "en"
    }
  ],
  "average_scores": {
    "workflow": {
      "trial_id_count": 4.1,
      "depth": 2.0,
      "relevance": 2.2,
      "clarity": 4.1,
      "completeness": 1.9,
      "trial_count_avg": 4.1,
      "execution_time_avg": 14.87,
      "avg_prompt_tokens": 1384.9,
      "avg_completion_tokens": 699.2,
      "avg_total_tokens": 2084.1,
      "total_prompt_tokens": 13849,
      "total_completion_tokens": 6992,
      "total_tokens": 20841,
      "total_scored": 10
    }
  }
}